Live Breaking News & Updates on Pharmacists Connect

Stay updated with breaking news from Pharmacists connect. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

OPC Summer 2024: Connecting Oncology Pharmacists With Cutting-Edge Insights and Opportunities to Collaborate

This year’s event from June 20 to 21, 2024, in Austin, Texas, will offer 4.25 BCOP CE hours. ....

United States , Zahra Mahmoudjafari , Hematology Oncology Pharmacy Association , American Society Of Clinical Oncology , University Of Kansas Health System , Pharmacists Connect , Oncology Pharmacy Association , Clinical Oncology , Annual Meeting , Pharmacy Practice , Cellular Therapeutics , Kansas Health System , Kansas City ,

NATALEE Trial Results Add Ribociclib to CDK4/6 Inhibitor Options in Early-Stage Breast Cancer

The benefit of ribociclib was seen as consistent against all of the stratification factors in the phase III study. ....

United States , Danielle Roman , American Society Of Clinical Oncology , Tersera Therapeutics , American Society , Clinical Oncology , Pharmacists Connect , Ovarian Ablation , Oncology Clinical Pharmacy Services , Allegheny Health Network ,

X-7/7 Trial Data May Change Prescribing Practices in Metastatic Breast Cancer

The single institution study compared fixed dose capecitabine to standard dose capecitabine to compare efficacy and tolerability in metastatic breast cancer. ....

United States , Danielle Roman , American Society Of Clinical Oncology , American Society , Clinical Oncology , Pharmacists Connect , Oncology Clinical Pharmacy Services , Allegheny Health Network ,

INDIGO Trial Provides First Randomized Data Supporting Use of IDH Inhibitor in Patients With IDH1/2 Mutating Gliomas

Heidi Finnes, PharmD, BCOP, FHOPA, addresses how the study data may impact the treatment of IDH1/2 mutating gliomas going forward. ....

United States , Heidi Finnes , Leadiant Biosciences , Clinical Ambulatory Pharmacy Practice , Mayo Clinic , Pharmacists Connect ,

Phase 3 ADAURA Trial Non-small Cell Lung Cancer Survival Results Provide Impactful Data, But Questions for Practice Setting Remain

Panelists discuss the potential impact of the study data presented at the ASCO 2023 Annual Meeting, which led to significant response from the field. ....

United States , United Kingdom , Leigh Boehmer , Mahsa Talbott , Amanda Cass , Thoracic Oncology Vanderbilt Ingram Cancer Center , American Society Of Clinical Oncology , Association Of Community Cancer Centers , American Society , Clinical Oncology , Pharmacists Connect , Tennessee Oncology , Community Cancer Centers ,